The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksEvgen Pharma Share Price (EVG)

Share Price Information for Evgen Pharma (EVG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.80
Bid: 0.75
Ask: 0.85
Change: 0.00 (0.00%)
Spread: 0.10 (13.333%)
Open: 0.80
High: 0.80
Low: 0.80
Prev. Close: 0.80
EVG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Evgen Pharma Plc Ord 0.25p

Evgen Pharma is listed in the FTSE AIM All-Share index.

Evgen Pharma is listed in the Medicine and Biotech sector.

Evgen Pharma Plc Ord 0.25p is listed on the London Stock Exchange trading with ticker code EVG.L. It has a market capitalisation of £3.42m, with approximately 427.35m shares in issue. Over the last year, Evgen Pharma share price has been traded in a range of 3.30, hitting a high of 4.05, and a low of 0.75.

Evgen Pharma Share Price
Price 0.80
Bid 0.75
Ask 0.85
Change 0.00 (0.00%)
Volume 0
Open 0.80
High 0.80
Low 0.80
Prev. Close 0.80
Currency GBX
Issue Country GB
Shares in Issue 427.35m
Market Capitalisation £3.42m
Market Size 30,000
52 Week High 4.05
52 Week High Date 10-May-2023
52 Week Low 0.75
52 Week Low Date 19-Apr-2024
# Trades 0
Vol. Sold 0
Sold Value £N/A
Vol. Bought 0
Bought Value £N/A
PE Ratio -0.544218
Earnings -1.47
Dividend 0.00
Yield 0.00%
Great for
Spread Betting and CFDs
Capital at risk.
Go to site
Great for
0% commission
Other fees apply.
Capital at risk.
Go to site
Great for
Larger Investment Pots
Capital at risk.
Go to site
Great for
Low Fees
Capital at risk.
Go to site

Recent Share Trades for Evgen Pharma (EVG)

Date Time Trade Prc Volume Buy/Sell Bid Ask Value  
  • No trades found.

Directors Deals for Evgen Pharma (EVG)

Announced Traded Action Notifier Price Currency Amount Holding
05-Apr-2405-Apr-24BuySusan (Sue) Foden held the position of Interim Chairman at the time of this trade.Susan (Sue) Foden1.00GBX600,000725,000
05-Apr-2405-Apr-24BuyToni Hänninen held the position of CFO at the time of this trade.Toni Hänninen1.00GBX1,000,0001,000,000
05-Apr-2405-Apr-24PlacingHuw Jones held the position of CEO at the time of this trade.Huw Jones1.00GBX3,000,0003,184,793
05-Apr-2405-Apr-24BuyHuw Jones held the position of CEO at the time of this trade.Huw Jones1.44GBX122,2933,184,793
31-Mar-2131-Mar-21Notification of HoldingSusan (Sue) Foden held the position of Non-Executive Director at the time of this trade.Susan (Sue) Foden0.000125,000
Evgen Pharma

Evgen Pharma is a clinical drug development company developing sulforaphane-based medicines focussed on the treatment of cancer and inflammation.

Evgen Pharma Home Page

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.